(a) General rule.--A manufacturer of an investigational drug, biological product or medical device may make available the manufacturer's investigational drug, biological product or medical device to eligible patients in accordance with this act.(b) Costs.--A manufacturer may:(1) Provide an investigational drug, biological product or medical device to an eligible patient without receiving compensation.(2) Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product or medical device.(c) Insurers.--Nothing in this act may be construed to require a health insurer to provide coverage for any health care services, including investigational drugs, biological products or medical devices, that would not otherwise be a covered benefit under an eligible patient's health insurance policy.Added by P.L. TBD 2017 No. 33, § 4, eff. 12/11/2017.